Ying Zhang

A novel agent attenuates cardiotoxicity and improves antitumor activity of doxorubicin in breast cancer cells

G. Cui, S. Lee, L. Shan, 2018, Journal of cellular biochemistry.

Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC.

Cheng Huang, Xiao-ming Meng, Jun Li, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Discovery of a Novel ERp57 Inhibitor as Antiplatelet Agent from Danshen (Salvia miltiorrhiza)

G. Cui, S. Lee, Jun Li, 2018, Evidence-based complementary and alternative medicine : eCAM.

Caffeic acid phenethyl ester protects against doxorubicin-induced cardiotoxicity and increases chemotherapeutic efficacy by regulating the unfolded protein response.

G. Cui, Ying Zhang, D. Kong, 2021, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

β-Glucan ameliorates nonalcoholic steatohepatitis induced by methionine and choline-deficient diet in mice.

G. Cui, Ying Zhang, D. Kong, 2020, Journal of food biochemistry.

Identification of dihydrotanshinone I as an ERp57 inhibitor with anti-breast cancer properties via the UPR pathway.

G. Cui, Ying Zhang, Hefeng Zhou, 2021, Biochemical pharmacology.

Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin

G. Cui, Jianyong Zhang, Ying Zhang, 2018, Molecules.

Mitochondrial complex I inhibition by homoharringtonine: A novel strategy for suppression of chronic myeloid leukemia.

G. Cui, Ying Zhang, Mengchen Liu, 2023, Biochemical pharmacology.